Men without chronic obstructive pulmonary disease (COPD) showed an associated difference in bone quality based on their smoking status and pack-years, according to a new study.
Bone density, measured by chest computed tomography (CTBD), was significantly altered in men without chronic obstructive pulmonary disease (COPD) based on their smoking status and pack-years, according to a study published this week in Scientific Reports.1
Smoking and bone mineral loss have been associated before, as male smokers with or without COPD were shown to have a definite risk of low CTBD and vertebral fractures.2 However, because these studies were conducted on patients with COPD, or in a general population that included patients with COPD, cases of low CTBD could be associated with the development of osteoporosis and emphysema in patients with COPD rather than smoking history. Researchers sought to investigate the relationship between smoking and CTBD in men without COPD to distinguish its association.
The cross-sectional study compared 1011 men 50 years or older without COPD on their smoking status in relation to their bone density, measured through CTBD, and bone mineral density, measured by dual-energy x-ray absorptiometry (DEXA-BMD). Data derived from the Ansan cohort included in the Korean Genome and Epidemiology Study (KoGES). The correlation between CTBD and DEXA-BMD was compared, as was the association of CTBD with pack-years:
Data showed an overall statistically significant lower CTBD of all vertebral bodies (VBs) for ever-smokers than in never-smokers. In participants younger than 65 years, CTBD levels of the T10 and L1 and mean CTBD of the T4, T7, and T10 were definitively lower in ever-smokers than in never-smokers (P <.05), whereas ever-smokers 65 years or older only showcased lower CTBD of L1. DEXA-BMD of all VBs, without L1, similarly showed definite differences among never, former, and current smokers.
CTBD was found to be lowest in heavy smokers, who showed significantly lower levels compared with light smokers (P <.05). Heavy and moderate smokers both exhibited a definite association with lower CTBD, which was not found in never-smokers. The correlations between CTBD and DEXA-BMD were significant at all VB levels (correlation coefficient, 0.448~0.640; P <.01), with an additional association with a smoker’s pack-years. This stark association between moderate and heavy smoking with lower CTBD, and CTBD’s subsequent correlation to DEXA-BMD, highlights the diminished bone quality in frequent smokers.
The study had limitations in its participants, as ever-smokers exhibited a heightened consumption of alcohol compared with never-smokers, which may contribute to lower CTBD. Its focus on a specific area in Korea may additionally represent data that do not apply to other populations.
Researchers provided extensive evidence of associations between smoking and lower CTBD in men, regardless of COPD diagnosis. The escalating correlation of CTBD and pack-years further reveals an individual’s increased risk based on their smoking history.
Reference
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
November 21st 2024Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
Read More
A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs
November 16th 2021On this episode of Managed Care Cast, we speak with MeiLan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the lungs and how they work, zooms out to examine the drivers of poor respiratory health, and addresses policy changes that are needed to improve lung health.
Listen
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks
October 23rd 2024Interstitial lung abnormalities (ILAs) in patients with chronic obstructive pulmonary disease (COPD) are linked to lower lung adenocarcinoma rates but higher rates of other cancers and heart failure.
Read More
Ineligibility, Limitations to PR Uptake in Patients With AECOPD
October 15th 2024Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) participated in post-discharge pulmonary rehabilitation (PR), with ineligibility significantly limiting uptake.
Read More